[1] 王秀岩,徐思成,刘光明,等.有创-无创序贯性机械通气治疗急性呼吸窘迫综合征的时机探讨[J].中华危重病急救医学,2014,26(5):330-334.
[2] 李昕,李雁,刘丽杰,等. 益气化瘀解毒方对急性呼吸窘迫综合征大鼠NF-κB/p38MAPK通路的影响[J]. 环球中医药,2017,10(3):275-279.
[3] 乔莉,张劲松,张华忠,等.氧合指数对有创机械通气治疗急性呼吸窘迫综合征患者预后的评估[J].中华急诊医学杂志,2014,23(3):257-260.
[4] 王宏飞,王勇强,高红梅,等.大承气汤在急性肺损伤/急性呼吸窘迫综合征患者机械通气治疗中的应用[J].山东医药,2015,4(12):33-34.
[5] 中华学会呼吸病学分会.急性肺损伤/急性呼吸窘迫综合征的诊断和治疗指南[J].中国危重病急救医学,2006,18(12):706-711.
[6] 中国中西医结合学会急救医学专业委员会.2001年全国中西医结合急救医学学术会议纪要[J].中国危重病急救医学,2001,13(12):766.
[7] 田雨,李杨.ARDS患者全身炎症反应及其治疗研究进展[J].临床肺科杂志,2014,19(2):340-342.
[8] Retamal J,Sörensen J,Lubberink M,et al.Feasibility of(68)Ga-labeled Siglec-9 peptide for the imaging of acute lung inflammation: a pilot study in a porcine model of acute respiratory distress syndrome[J].Am J Nucl Med Mol Imaging,2016,6(1):18-31.
[9] Güldner A,Braune A,Ball L,et al.Comparative Effects of Volutrauma and Atelectrauma on Lung Inflammation in Experimental Acute Respiratory Distress Syndrome[J].Crit Care Med,2016,31(4):85-86.
[10] Nakao A,Ishii H,Igata F,et al.Disseminated tuberculosis with acute respiratory distress syndrome lacking granuloma formation in the lung[J].J Infect Chemother,2016,5(4):86-90.
[11] Preira P,Forel JM,Robert P,et al.The leukocyte-stiffening property of plasma in early acute respiratory distress syndrome(ARDS)revealed by a microfluidic single-cell study: the role of cytokines and protection with antibodies[J].Crit Care,2016,12(4):86-90.
[12] Aeffner F,Bolon B,Davis IC3,et al.Mouse Models of Acute Respiratory Distress Syndrome: A Review of Analytical Approaches, Pathologic Features, and Common Measurements[J].Toxicol Pathol,2015,43(8):1074-1092.
[13] 尤莉莉,刘燕,杨铁柱,等.“肺肠同治”在骨创伤后ARDS患者呼吸与肠屏障功能障碍中的应用及疗效评价[J].中国中医急症,2015,24(3):399-401.
[14] 任珏辉,陈建荣,高想,等.清肺汤治疗ARDS疗效观察及对ET-1和8-iso-PG水平的影响[J].南京中医药大学学报,2015,31(4):323-326.
[15] 黄瑞音,李雁,李昕,等. 益气化瘀解毒方治疗内毒素致ARDS大鼠的炎症作用研究[J]. 环球中医药,2017,10(2):141-145.